Status:
COMPLETED
An Observational Study on the Prevalence of Human Papillomavirus Types in Women in the Kingdom of Bahrain
Lead Sponsor:
GlaxoSmithKline
Conditions:
Human Papillomavirus Infection
Eligibility:
FEMALE
16+ years
Brief Summary
The purpose of this study is to determine the Human Papillomavirus (HPV) prevalence and HPV type distribution among women ≥ 20 years of age attending routine cervical screening and among women ≥ 16 ye...
Eligibility Criteria
Inclusion
- Women ≥ 20 years of age attending a clinic for routine cervical screening OR
- Women ≥ 16 years of age presenting for post-natal check-ups
- Women providing a cervical sample
- Written informed consent or oral-witnessed thumb printed informed consent obtained from the subject
Exclusion
- Referral for abnormal cervical sample at the current visit
- Abundant menstrual bleeding or vaginal discharge not allowing appropriate screening to be performed (Note: Enrolment can be delayed until this condition is resolved)
- Pregnant women
- History of hysterectomy
- Known diagnosis of immunosuppression, or patient on immunosuppressives
- Having received one or more doses of human papillomavirus vaccine prior to participating in the study
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
552 Patients enrolled
Trial Details
Trial ID
NCT01205412
Start Date
October 1 2010
End Date
November 1 2011
Last Update
November 22 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Manama, Bahrain